Trial Profile
Efficacy and safety study of lisdexamfetamine in preschool-age children with attention deficit hyperactivity disorder (ADHD)
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 25 Jun 2014
Price :
$35
*
At a glance
- Drugs Lisdexamfetamine (Primary)
- Indications Attention-deficit hyperactivity disorder
- Focus Therapeutic Use
- 25 Jun 2014 New trial record